Braxia Scientific Corp C.BRAX

Alternate Symbol(s): BRAXF

Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP) development platform. The Company has clinic operations in the Canadian cities of Mississauga, Toronto, Kitchener-Waterloo, Ottawa and Montreal. The Company, through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., it operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Ottawa, Kitchener and Montreal. Its subsidiaries include Altmed Capital Corp., Artisan Growers Ltd., KetaMD, Inc., Novo Formulations Ltd. and Tassili Life Sciences Corp.

CSE:BRAX - Post by User

Braxia Scientific Corp > Proposed Settlement in Class Action Lawsuit Against Braxia

<< Previous

Bullboard Posts

Next >>

Comment by KNDlawon May 10, 2022 6:50pm

160 Views

Post# 34672290

RE:Proposed Settlement in Class Action Lawsuit Against Braxia

Good day all,

Due to a conflict that arose in the schedule of the Supreme Court of British Columbia, the hearing for approval of the proposed settlement in the class action against Braxia Scientific Corp. has been moved from July 15, 2022 to July 18, 2022.

Further information about the proposed settlement is available at: https://knd.law/class-actions/braxia-scientific-corp/

Best,
KND Complex Litigation

<< Previous

Bullboard Posts

Next >>

PharmAla Biotech launches educational portal for MDMA